Skip to content

To explore the clinical efficacy and possible mechanism of acupuncture in the treatment of herpes zoster based on P2X7R and proteomics

Clinical and mechanism study of acupuncture treatment of herpes zoster

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065225
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster and postherpetic neuralgia

Interventions

The control group:Medicine
Experimental group:Medicine + Acupuncture

Sponsors

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of traditional Chinese and western medicine for herpes zoster. (2) Age >= 50 and = 4 points, first diagnosis and treatment. (4) Voluntarily participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Special types of herpes zoster, including ocular and visceral herpes zoster, occult herpes zoster, etc.; (2) Patients who were allergic to the drugs used in this study (valaciclovir, mecobalamin, pregabalin); (3) The site of the disease is not suitable for puncture cupping, such as the head and face, perineum, etc.; (4) women during menstruation, pregnancy or lactation; (5) Patients with other serious organ diseases, malignant tumors, immune dysfunction, liver and kidney insufficiency, and mental diseases; (6) Patients with blood diseases with abnormal coagulation function or severe diabetes with poor glycemic control; (7) Patients suffering from other chronic painful diseases requiring the use of analgesics; (8) have taken immunomodulators, antiviral drugs and/or antibiotics in the past two weeks; (9) Have participated in or are participating in other clinical investigators 3 months before enrollment.

Design outcomes

Primary

MeasureTime frame
Incidence of pain;

Countries

China

Contacts

Public ContactLi Jing

Yueyang Hospital of Integrated Chinese and Western Medici

1971921250@qq.com+86 18930568565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026